Literature DB >> 11485913

Proliferation and remodeling of the peritubular microcirculation after nephron reduction: association with the progression of renal lesions.

E Pillebout1, M Burtin, H T Yuan, P Briand, A S Woolf, G Friedlander, F Terzi.   

Abstract

Little is known about the serial changes that might occur in renal capillaries after reduction of renal mass. In the current study, our aim was to document potential alterations in the morphology and proliferation of the renal cortical peritubular microcirculation at specific time points (7 and 60 days) after experimental 75% surgical nephron reduction using two strains of mice that we here demonstrate react differently to the same initial insult: one strain (C57BL6xDBA2/F1 mice) undergoes compensatory growth alone, whereas the other (FVB/N mice) additionally develops severe tubulo-interstitial lesions. Our data demonstrate that significant remodeling and proliferation occur in renal cortical peritubular capillaries after experimental nephron reduction, as assessed by microangiography using infusion of fluorescein isothiocyanate-labeled dextran, expression of the endothelial markers CD34 and Tie-2, and co-expression of CD34 and proliferating cell nuclear antigen, a surrogate marker of cell proliferation. This was accompanied by an increase of renal vascular endothelial growth factor protein levels and a change in distribution of this protein within the kidney itself. Moreover, most of these responses were accentuated in FVB/N mice in the presence of progressive renal disease and positively correlated with tubular epithelial cell proliferation. Hence, we have made three significant novel observations that illuminate the complex pathophysiology of chronic kidney damage after nephron reduction: 1) cortical peritubular capillaries grow by proliferation and remodeling, 2) vascular endothelial growth factor expression is altered, and 3) the development of tubulo-interstitial disease is genetically determined.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11485913      PMCID: PMC1850535          DOI: 10.1016/S0002-9440(10)61726-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

Review 1.  Therapeutic intervention in glomerulonephritis by oligonucleotides.

Authors:  N Kashihara; Y Maeshima; H Makino
Journal:  Exp Nephrol       Date:  1997 Mar-Apr

2.  Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation.

Authors:  G Helmlinger; F Yuan; M Dellian; R K Jain
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

3.  Peritubular capillary injury during the progression of experimental glomerulonephritis in rats.

Authors:  Ryuji Ohashi; Hiroshi Kitamura; Nobuaki Yamanaka
Journal:  J Am Soc Nephrol       Date:  2000-01       Impact factor: 10.121

4.  Effect of tissue factor deficiency on mouse and tumor development.

Authors:  J R Toomey; K E Kratzer; N M Lasky; G J Broze
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

Review 5.  Significance of postglomerular capillaries in the pathogenesis of chronic renal failure.

Authors:  A Bohle; S Mackensen-Haen; M Wehrmann
Journal:  Kidney Blood Press Res       Date:  1996       Impact factor: 2.687

6.  Vascular endothelial growth factor is an essential molecule for mouse kidney development: glomerulogenesis and nephrogenesis.

Authors:  Y Kitamoto; H Tokunaga; K Tomita
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

7.  Sodium restriction decreases AP-1 activation after nephron reduction in the rat: role in the progression of renal lesions.

Authors:  F Terzi; M Burtin; M Hekmati; C Jouanneau; H Beaufils; G Friedlander
Journal:  Exp Nephrol       Date:  2000 Mar-Apr

8.  The lack of a functional p21(WAF1/CIP1) gene ameliorates progression to chronic renal failure.

Authors:  J Megyesi; P M Price; E Tamayo; R L Safirstein
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

9.  Expression of vascular endothelial growth factor in renal vascular disease and renal allografts.

Authors:  H J Gröne; M Simon; E F Gröne
Journal:  J Pathol       Date:  1995-11       Impact factor: 7.996

10.  Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases.

Authors:  K Shulman; S Rosen; K Tognazzi; E J Manseau; L F Brown
Journal:  J Am Soc Nephrol       Date:  1996-05       Impact factor: 10.121

View more
  27 in total

1.  Lipocalin 2 is essential for chronic kidney disease progression in mice and humans.

Authors:  Amandine Viau; Khalil El Karoui; Denise Laouari; Martine Burtin; Clément Nguyen; Kiyoshi Mori; Evangéline Pillebout; Thorsten Berger; Tak Wah Mak; Bertrand Knebelmann; Gérard Friedlander; Jonathan Barasch; Fabiola Terzi
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

2.  TGF-alpha mediates genetic susceptibility to chronic kidney disease.

Authors:  Denise Laouari; Martine Burtin; Aurélie Phelep; Carla Martino; Evangeline Pillebout; Xavier Montagutelli; Gérard Friedlander; Fabiola Terzi
Journal:  J Am Soc Nephrol       Date:  2010-12-23       Impact factor: 10.121

Review 3.  Potential approaches to reverse or repair renal fibrosis.

Authors:  Desiree Tampe; Michael Zeisberg
Journal:  Nat Rev Nephrol       Date:  2014-02-11       Impact factor: 28.314

4.  JunD protects against chronic kidney disease by regulating paracrine mitogens.

Authors:  Evangéline Pillebout; Jonathan B Weitzman; Martine Burtin; Carla Martino; Pierre Federici; Moshe Yaniv; Gérard Friedlander; Fabiola Terzi
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

5.  Inhibition of tubulointerstitial fibrosis by pentoxifylline is associated with improvement of vascular endothelial growth factor expression.

Authors:  Qiu-gen Zhou; Fa-lei Zheng; Fan-fan Hou
Journal:  Acta Pharmacol Sin       Date:  2008-12-15       Impact factor: 6.150

6.  Dysmorphogenesis of kidney cortical peritubular capillaries in angiopoietin-2-deficient mice.

Authors:  Jolanta E Pitera; Adrian S Woolf; Nicholas W Gale; George D Yancopoulos; Hai Tao Yuan
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

7.  Maternal environment interacts with modifier genes to influence progression of nephrotic syndrome.

Authors:  Julien Ratelade; Tiphaine Aguirre Lavin; Andrea Onetti Muda; Ludivine Morisset; Géraldine Mollet; Olivia Boyer; Deborah S Chen; Anna Henger; Matthias Kretzler; Norbert Hubner; Clotilde Théry; Marie-Claire Gubler; Xavier Montagutelli; Corinne Antignac; Ernie L Esquivel
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

Review 8.  Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease.

Authors:  Yujiro Kida; Bie Nga Tchao; Ikuyo Yamaguchi
Journal:  Pediatr Nephrol       Date:  2013-03-10       Impact factor: 3.714

Review 9.  Progression of glomerular and tubular disease in pediatrics.

Authors:  Robert P Woroniecki; H William Schnaper
Journal:  Semin Nephrol       Date:  2009-07       Impact factor: 5.299

10.  Galectin-3, a novel centrosome-associated protein, required for epithelial morphogenesis.

Authors:  Annett Koch; Francoise Poirier; Ralf Jacob; Delphine Delacour
Journal:  Mol Biol Cell       Date:  2009-11-18       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.